NCT06869603 Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic
| NCT ID | NCT06869603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS SYNLAB SDN |
| Condition | Renal Stones |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-12-07 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-12-07 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this research protocol is to evaluate the adherence to the Mediterranean diet in patients suffering from recurrent kidney stones and osteometabolic diseases. Results of the study will allow to assess the dietary habits of patients with the above diseases. Given the universal prevalence of nephrolithiasis and osteometabolic diseases, the knowledge of these data appears crucial for the proper management of the dietary approach to prophylaxis secondar
Eligibility Criteria
Inclusion Criteria: * Patients with idiopathic relapsing nephrolithiasis with evidence instrumental of bilateral renal stones or emission of more than one stone in the past 5 years Exclusion Criteria: * Patients who had albumin-corrected plasma calcium levels \> 11.0 mg/dl at the time of the first determination of serum levels of 25 OH vitamin D; * Patients who had glomerular filtration rate \< 60 mL/min/1.73 m2; * Patients who had positive personal history of chronic granulomatous disease; * pregnancy patients; * Positive personal history for morphological abnormalities of the excretory system; * incomplete data collection.
Frequently Asked Questions
Who can join the NCT06869603 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Renal Stones. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06869603 currently recruiting?
Yes, NCT06869603 is actively recruiting participants. Visit ClinicalTrials.gov or contact IRCCS SYNLAB SDN to inquire about joining.
Where is the NCT06869603 trial being conducted?
This trial is being conducted at Naples, Italy.
Who is sponsoring the NCT06869603 clinical trial?
NCT06869603 is sponsored by IRCCS SYNLAB SDN. The trial plans to enroll 50 participants.